ArticleRheumatology and therapy2025

Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.